Proactive, Integrated Approach Including Vaccination Critical To Control Dengue

Huffington Post: 4 Billion People At Risk Of Being Infected With The Fastest Growing Mosquito-Borne Disease
Melvin Sanicas, vaccinologist and public health physician

“…No specific antiviral therapy exists [for dengue], but after decades of research, we now have a vaccine. A vaccine could have a major public health impact if the particular disease has a high incidence. The effect on the overall incidence of dengue will depend largely on the number of people who become vaccinated. The approach to dengue is almost always reactive — only when there is an outbreak. It is important to be pro-active in controlling dengue before it becomes an even greater threat. An integrated approach of vector control, public awareness, monitoring and surveillance, and vaccination will lead to great progress in the control of the disease and will eliminate dengue as a public health problem firstly in endemic areas” (3/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.